EX-99.1 2 tm237162d1_ex99-1.htm EXHIBIT 99.1

 

CUSIP NO. 74349U 108    

 

Exhibit 99.1

 

Agreement of Reporting Persons

 

In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended (the “Act”), Cedars Sinai Intellectual Property Company, Cedars-Sinai Medical Center, Thomas M. Priselac, and David M. Wrigley hereby agree to file jointly the statement on this Schedule 13G/A (this “Schedule 13G/A”) to which this Agreement is attached and any further amendments thereto which may be deemed necessary, pursuant to Regulation 13D-G under the Act.

 

It is understood and agreed that each of the parties hereto is responsible for the timely filing of such statement and any amendments thereto, and for the completeness and accuracy of the information concerning such party contained therein, but such party is not responsible for the completeness and accuracy of information concerning any other party unless such party knows or has reason to believe such information is inaccurate.

 

It is understood and agreed that a copy of this Agreement shall be attached as an exhibit to the statement on this Schedule 13G/A, and any amendments thereto, filed on behalf of each of the parties hereto.

 

CEDARS SINAI INTELLECTUAL PROPERTY COMPANY, INC.   CEDARS-SINAI MEDICAL CENTER
     
By: /s/ James D. Laur   By: /s/ David M. Wrigley
Name: James D. Laur   Name: David M. Wrigley
Title: Chief Executive Officer   Title: Executive Vice President and Chief Financial Officer
     
David M. Wrigley   THOMAS M. PRISELAC
     
/s/ David M. Wrigley   /s/ Thomas M. Priselac